Enova International, Inc. (ENVA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $230.58, Enova International, Inc. (ENVA) is priced for +1.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/ENVA

Headline

FieldValue
TickerENVA
CompanyEnova International, Inc.
Sector / IndustryFinancial Services
Current price$230.58/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)7.5%
Operating margin today24.0%
Margin compression (value-band)-16.5pp
Implied growth1.0%
Multiple paid13x operating income

The operating-margin figure is value-band context at year 7: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.9% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: n/a

ReferenceValue
vs own history-0.97σ

Valuation X-Ray

The price is supported by earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.49x5expensive
Earnings1.06x4expensive
Relative0.52x4justifies
Growth0.75x2justifies

Families that justify the price: Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.6%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
DCF Exit MultipleGrowth$753.980.31xyesExit EV/EBITDA: 10.3x / 12.3x / 14.3x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$201.481.14xyesP/E 12x (static sector reference · 2026-04), scenarios: 9.8x / 12.0x / 14.2x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$154.341.49xyesBV/sh $60.13, ROE (TTM) 23.7%, ke 9.3%
Two-Stage Excess ReturnAsset$247.320.93xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$194.271.19xyesRev $3.4B, growth 18% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.0x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$470.050.49xyesEPS $13.43, growth 35% (input: historical EPS growth), PEG=0.46 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$77.702.97xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.55B × (1−25%) / WACC 5.6% → EPV (no growth)
Residual IncomeAsset$225.821.02xyesBV $60.13 + 5yr PV of (ROE (TTM) 23.7% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$134.791.71xyes√(22.5 × EPS $13.43 × BVPS $60.13) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$651.430.35xyesFCF $1952.8M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$433.340.53xyesEPS $13.43 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$29.787.74xyesBV $60.13 × (ROIC 2.8% / WACC 5.6%)
P/Sales SectorRelative$415.220.56xyesRevenue $3.45B × sector P/S 3.0x
PEG Fair ValueRelative$503.620.46xyesEPS $13.43 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$145.191.59xyesEPS $13.43 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Enova (consolidated online financial services)operatingenterprise3.2B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$4.9b
Net debt / NOPAT (after-tax)7.88x
Net debt / operating income (pre-tax)5.91x
Interest coverage2.3x
Share count CAGR (buyback)-5.9%
Burning cashno

Bullet Takeaways

Bull Case

Lenders are awkward to value because reported profit depends on a guess about losses that have not happened yet, and every lender makes that guess somewhere different. Most build a reserve against loans carried at cost, then release or add to it slowly enough that a bad year takes several years to show. Enova does the opposite. The company utilizes the fair value option on its entire loan and finance receivable portfolio, which means the whole book is remarked each period and the remark runs through the income statement immediately. There is no reserve to smooth. In 2025 the change in fair value took 41.9% of revenue back out before net revenue was struck, against 42.5% the year before.

Two years of marks that barely move is information, and it is the bull's best evidence. At the end of 2025 the portfolio carried at $5,471.5 million against outstanding principal of $4,748.0 million, a fair value equal to 115.2% of principal. The earnings arrived alongside the marks rather than instead of them: net income of $308.4 million in 2025 against $209.4 million in 2024, with diluted earnings per share of $11.52 against $7.43. A company overstating its book tends not to also report the earnings underneath it.

The engine underneath has quietly changed shape. The small business book grew 34.0% in 2025 to a combined balance of $3,328.5 million while the consumer book grew 5.9% to $1,596.1 million, and small business moved to 43.2% of revenue from 39.3%. That side also earns better. The first-quarter 2026 report states that the revenue margin related to our small business loans and finance receivables was 69.2% for the current quarter, which is consistent with the prior four sequential quarters, which had an average net revenue margin of 69.9%, as credit performance and yields were steady. Consolidated income from operations rose 20.5% to $207.1 million in that quarter.

Against the cohort the growth is real rather than relative. Revenue grew about 17.6% over the trailing year. OMF grew 8.8%, CACC 4.5%, BFH 2.5% and SLM 2.3%. Only LC at 25.4% and SOFI at 40.7% grew faster, and both of those do it holding a bank charter, which is a materially cheaper way to buy the raw material. SOFI puts the advantage plainly in its own annual report: Operating as a bank allows for expanded access to multiple channels of funding, including deposits through SoFi Bank and borrowing capacity through the FHLB and Federal Reserve, which provides increased optionality in sourcing liquidity through different environments and periods of capital markets volatility. That sentence is the reason Enova agreed to buy Grasshopper Bank, and it is the single largest change available to this business.

What holds the downside together in the meantime is an unglamorous structural fact about lending books: they run off. As the annual report puts it, To the extent we experience short-term or long-term funding disruptions, we have the ability to adjust our volume of lending and financing to consumers and small businesses that would reduce cash outflow requirements while increasing cash inflows through repayments. Stop originating and the balance sheet turns into cash on its own schedule. Meanwhile the share count has been shrinking on purpose: diluted weighted-average shares fell from 31,921 thousand in 2023 to 28,202 thousand in 2024 and 26,775 thousand in 2025, and the board authorized a further share repurchase program totaling $400.0 million through June 30, 2027.

Bear Case

On July 10, 2026, two of Enova's directors resigned from the board effective immediately, both of them members of the Audit Committee, and the board was reduced to ten seats the same day. The filing states the resignations were not the result of any disagreement with the company over its operations, policies or practices, and nothing in the record contradicts that. It was still an unusual week for the committee whose job is to sign off on the hardest number in the business.

That number is the loan book itself. Enova does not carry loans at cost; it carries them at what its own cash-flow models say they are worth, using inputs no outsider can observe. The 2025 annual report says so in the auditor's own framing: Given management's use of unobservable inputs to estimate the fair value of the loans and finance receivables, performing audit procedures to evaluate these inputs requires a high degree of auditor judgment. The mechanism is spelled out too. The payment status of a customer, including the degree of any delinquency, is a significant factor in determining estimated charge-offs in the cash flow models that we use to determine fair value. Today's delinquency is observable. What it turns into is a projection, and the projection is what sets reported profit.

Read the disclosed sensitivities and the exposure sharpens rather than softens. The company discloses that An increase of 100 basis points to the discount rates used in our valuations would decrease the balance of loans and finance receivables at fair value by approximately 0.54%. That is a small number, and small is the point: the carrying value barely responds to interest rates, which means it responds to the credit assumptions instead. Rates are published. Credit assumptions are not.

Capital allocation is drifting away from the shareholder at the same time. Retiring stock has been the quiet engine of per-share growth here, with diluted weighted-average shares falling from 31,921 thousand in 2023 to 26,775 thousand in 2025. That engine is throttling back. In the second quarter of 2026 the company repurchased $19 million of common stock while originations rose 27% and the combined loan book reached a record $5.5 billion. Capital is going into the book and into a bank acquisition instead. Both may be better uses of it. Neither does what buying back a tenth of the shares does to earnings per share.

Then there is the standing question of whether the products stay legal where they are sold. The annual report does not hedge it: Additional legislative or regulatory provisions could be enacted that could severely restrict, prohibit or eliminate our ability to offer a consumer or small business loan or financing product. It goes further on the legal architecture the industry leans on, warning that In some circumstances, federal preemption and application of an out-of-state choice of law provision will not, or may not, be available for the benefit of certain non-bank purchasers of loans to defend against a state law claim of usury. A lender whose product legality is decided state by state carries a discount that no quarter of good credit performance removes.

Funding is the last piece. The weighted-average interest rate on outstanding debt was 8.64% in 2025, down from 9.31% in 2024, and the newest facility amendment prices its junior tranche at SOFR plus 7.50% inside a 420,000,000 dollar commitment. Operating income covers the interest bill 2.2 times over. For a lender the interest bill is the cost of the goods, not an afterthought, so a widening funding spread compresses the margin directly rather than eventually.

Put together, the bear case here is not that the price is too high. Most of the ways of valuing this company reach it. The bear case is that the discount attached to it is deserved, and that the three things holding it down, the opacity of the marks, the state-by-state legality of the product, and the cost of borrowed money, are exactly the three things a good quarter cannot fix.

Valuation

Fourteen times operating income is not a demanding number for a business whose revenue grew about 17.6% over the trailing year, and understanding why the market pays it is most of the work. Run the price backwards and it embeds company-wide operating growth of roughly 5.4% a year over a five-year stage. That is well inside what Enova has recently delivered, and against its sector the multiple sits in the lower half of the peer range. One caution on how firmly to hold that figure: computed at a cost of capital near 9.2%, a single percentage point of movement in that rate shifts the implied growth by close to 6 percentage points. The direction of the read is solid. The decimal is not.

The unusual feature of this name is that most of the lenses reach the price rather than falling short of it. The earnings-power methods, the peer-multiple methods and the forward-growth methods all land at or above where the shares trade. The lens that does not is the asset-value one, which starts from book value of $53.20 a share and works up from there.

There is a wrinkle in that disagreement worth sitting with, because the two sides are drawing on the same model. Book value here is not a historical-cost number; the assets inside it are marked to the company's own estimates. Return on equity of 23.3% against that book is what lets the earnings lenses reach the price, and the same marks set the book the asset lens says is too small. If the estimates are honest, the asset lens is simply the wrong tool for a business whose value is its underwriting rather than its collateral. If they run optimistic, both lenses are wrong in the same direction at once, and the earnings one is wrong by more.

The cohort places the multiple rather than defending it. Growth at Enova ran ahead of OMF at 8.8%, CACC at 4.5%, BFH at 2.5% and SLM at 2.3% over the trailing year, and behind LC at 25.4% and SOFI at 40.7%. Faster than most of the cohort, priced in the lower half of it. The gap between those two facts is the accounting and the regulatory posture, not the operating performance.

Solvency reads differently for a lender than for anything else, and the difference matters here. About 4.7 billion dollars of net borrowing, roughly 6.2 times operating profit with the interest bill covered 2.2 times over, would be a warning on an industrial balance sheet. On this one the borrowing is the inventory: it funds a loan book that repays itself on a schedule, and the annual report is explicit that slowing originations converts the book to cash rather than requiring a rescue. The question the balance sheet raises is therefore not whether the debt gets repaid. It is whether the assets standing behind it are worth what the models say, which is the same question every other part of this report keeps arriving at.

Catalysts

Second-quarter results landed on July 23, 2026 and were strong on the reported lines. Revenue of $929 million rose 22% from $764 million a year earlier, net income reached $105 million or $4.00 per diluted share against $76 million and $2.86, and the combined loan book hit a record $5.5 billion on originations of $2.3 billion in the quarter, up 27%. The consolidated net charge-off ratio came down to 7.3% and the net revenue margin improved to 61% from 58%. Management said on the same release that it was raising its outlook for the year.

The larger event is still pending. Enova has agreed to acquire Grasshopper Bank and has filed a registration statement on Form S-4 with the SEC carrying a Grasshopper proxy statement and an Enova prospectus; on the July call the company described regulators as still working through the application review and said it expects to close later this year. Nothing about the deal is done until the regulators finish, so it belongs on the watch list rather than in the numbers. What is at stake is the cost of money. Enova's weighted-average interest rate on outstanding debt was 8.64% in 2025; deposits, if the charter arrives, are a different and cheaper class of funding entirely.

Two smaller items filed in the same window are worth tracking. On June 25, 2026 the company amended one of its securitization facilities, taking the total commitment to 420,000,000 dollars with the revolving period running to June 2028 and maturity in June 2029, priced at a blended spread of 3.36% over commercial paper and SOFR rates. And on July 10, 2026 two Audit Committee members resigned from the board, which was reduced to ten seats, with Maria Veltre elected the same day and added to the compensation committee days later. For a company whose earnings rest on internal valuation models, the composition of the audit committee is not a housekeeping detail.

Peer Cohorts (Per Segment, With Filing Citations)

Enova (consolidated online financial services) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q2 2026 earnings release, July 23, 2026 · company 8-K, July 10, 2026 · company 8-K, June 25, 2026 · company 8-K, July 10, 2026, and 8-K/A, July 15, 2026

View the full interactive ENVA report on boothcheck